Ask AI about Phyteau
Post your question publicly — other visitors, and whoever manages this page, can answer. It will be visible on this page.
Want to hear about this company again? Follow it and we’ll email you when a new review appears.
AI-generated from reviews on this page. Verify anything important with the company directly.
0 Reviews
Deutsch
No reviews
Questions & Answers
No questions yet — be the first to ask.
Sign in to post
Your text is saved — you'll come right back to post.
Don't have an account? Create one
News & Press
No news yet. This is where the business shares its own updates and press.
Photos
No photos yet. Photos shared by reviewers will show up here.
About Phyteau
Phyteau is developing a new class of therapeutics for diabetes, obesity, weight-loss, and related metabolic condition like NAFLD and NASH. The company's therapeutics work in the intestines where they trigger key cellular receptors causing the release of therapeutic levels of key metabolic hormones, like GLP-1, PYY and CCK. The hormones work naturally and safely to control blood sugar, appetite, food intake, and metabolism.
The company continues to develop new solutions to help people around the world suffering from metabolic diseases.
Phyteau was founded on 2017 and is headquartered in Santa Fe, New Mexico.
- Website
- phyteau.co
- [email protected]
